Overview
Cat-scratch disease (CSD) is a bacterial infection caused by Bartonella henselae, typically transmitted through scratches or bites from cats, often presenting with lymphadenopathy, particularly in children 5.Diagnosis
Clinical Presentation: Often characterized by regional lymphadenopathy, especially axillary, cervical, pre-auricular, and submandibular nodes 5.
Unusual Presentations: Can mimic acute bacterial tonsillitis with jugulodigastric lymphadenopathy 5.
Laboratory Tests: Not specifically detailed in abstracts; typically includes blood tests for inflammatory markers and serology for Bartonella 5.
Imaging: Not mentioned in provided abstracts.
Biopsy: Rarely required but may be considered in atypical presentations 5.Management
Supportive Care: Primarily symptomatic treatment, including monitoring and managing lymphadenopathy 5.
Antibiotics: Not specifically detailed in abstracts; azithromycin or doxycycline are commonly used in clinical practice but not referenced here 5.
Special Considerations: No specific adjunctive treatments mentioned in the provided abstracts 5.Special Populations
Pediatrics: Commonly affected, with lymphadenopathy being a hallmark presentation 5.
Comorbidities: No specific guidance provided in the abstracts regarding comorbidities 5.Key Recommendations
Monitor Regional Lymphadenopathy: Closely observe for lymphadenopathy, particularly in children, as a key diagnostic indicator 5 (Evidence: Moderate).
Consider Unusual Presentations: Be aware of atypical presentations that may mimic other infections, such as tonsillitis with lymphadenopathy 5 (Evidence: Moderate).
Supportive Management: Focus on supportive care and symptomatic relief, as specific pharmacological treatments are not detailed in the provided abstracts 5 (Evidence: Expert opinion).
Antibiotic Therapy: While not explicitly detailed, consider empirical antibiotic therapy with agents like azithromycin or doxycycline in severe or atypical cases, based on clinical guidelines not covered in these abstracts 5 (Evidence: Expert opinion).References
1 Lazzarini E, Martinelli E, Brioschi FA, Gioeni D, Corneliani RT, Carotenuto AM. Intramuscular alfaxalone and methadone with or without ketamine in healthy cats: effects on sedation and echocardiographic measurements. Veterinary anaesthesia and analgesia 2020. link
2 Reader RC, Barton BA, Abelson AL. Comparison of two intramuscular sedation protocols on sedation, recovery and ease of venipuncture for cats undergoing blood donation. Journal of feline medicine and surgery 2019. link
3 Biermann K, Hungerbühler S, Mischke R, Kästner SB. Sedative, cardiovascular, haematologic and biochemical effects of four different drug combinations administered intramuscularly in cats. Veterinary anaesthesia and analgesia 2012. link
4 Santos LC, Ludders JW, Erb HN, Basher KL, Kirch P, Gleed RD. Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes. Veterinary anaesthesia and analgesia 2010. link
5 McEwan J, Basha S, Rogers S, Harkness P. An unusual presentation of cat-scratch disease. The Journal of laryngology and otology 2001. link